Donald Wuchterl
Director/Board Member chez ABEONA THERAPEUTICS INC.
Fortune : 545 033 $ au 31/03/2024
Profil
Donald A.
Wuchterl is an Independent Director at Abeona Therapeutics, Inc. and Senior VP & Chief Manufacturing Officer at T-Knife Therapeutics, Inc. He was previously the Chief Operating Officer & Senior Vice President at Cytovance Biologics, Inc. and Senior VP-Technical Operations & Quality at Astellas Gene Therapies, Inc. He holds an undergraduate degree from Colorado Technical University, Inc. and an MBA from Fitchburg State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/03/2024 | 75 177 ( 0,27% ) | 545 033 $ | 31/03/2024 |
Postes actifs de Donald Wuchterl
| Sociétés | Poste | Début |
|---|---|---|
| ABEONA THERAPEUTICS INC. | Director/Board Member | 19/04/2021 |
| T-Knife Therapeutics, Inc. | Corporate Officer/Principal | - |
Anciens postes connus de Donald Wuchterl
| Sociétés | Poste | Fin |
|---|---|---|
| AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Chief Operating Officer | - |
Formation de Donald Wuchterl
| Colorado Technical University, Inc. | Undergraduate Degree |
| Fitchburg State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABEONA THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
| T-Knife Therapeutics, Inc. |
